Rituximab therapy in Greek patients with rheumatoid arthritis
Aristotelis P Tsiakalos*, Nestor K Avgoustidis*, Haralampos M MoutsopoulosDepartment of Pathophysiology, Medical School, National Univercity of Athens, Athens, Greece. *These authors contributed equally to this workObjective: An open-label, prospective, uncontrolled study created to investigate clin...
Enregistré dans:
Auteurs principaux: | Haralampos M Moutsopoulos, Nestor K Avgoustidis, Aristotelis P Tsiakalos |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2008
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c6da35654e354f3ab0f1665dc902d33c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
par: Joseph M Tuscano, et autres
Publié: (2009) -
Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
par: Benucci M, et autres
Publié: (2013) -
NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab
par: Re KA, et autres
Publié: (2012) -
NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]
par: Lurati A, et autres
Publié: (2013) -
Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure
par: Kekow J, et autres
Publié: (2012)